Work

Safety and Efficacy of Venetoclax (ABT-199/GDC-0199) in Combination with Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 1b Results

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.3038.3038

Authors: Philippe Moreau, Asher Chanan-Khan, Andrew W. Roberts, Amit B. Agarwal, Thierry Facon, Shaji Kumar, Cyrille Touzeau, David Darden, Lura Morris, Jeremy Ross, Ahmed H Salem, Wijith Munasinghe, Ming Zhu, Joel Leverson, Paulo Maciag, Sari Heitner Enschede, Maria Verdugo, Rod A. Humerickhouse, Simon Harrison

Institutions: Centre Hospitalier Universitaire de Nantes, Mayo Clinic in Florida, The Royal Melbourne Hospital, University of Arizona, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, Mayo Clinic, AbbVie (United States), Peter MacCallum Cancer Centre

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559486183

FWCI: 4.278

Cites:

Cited by: 20

Related to: 10